014950 — Samik Pharm Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual cashflow statement for Samik Pharm, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	Annual Audited Accounts
Standards:	KAS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final
Net Income/Starting Line	344	2,969	3,522	-755
Depreciation
Amortisation
Non-Cash Items	2,543	229	1,408	5,078
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-1,382	-2,228	-1,897	-3,622
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	2,664	2,248	4,385	2,077
Capital Expenditures	-1,477	-1,377	-848	-3,432
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-204	-491	-1,313	2,279
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-1,680	-1,868	-2,161	-1,153
Financing Cash Flow Items	—	-141	-282	0
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-141	-250	253	-256
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	844	131	2,477	669